820
D. Kavvadias et al
Hispidulin, a benzodiazepine receptor ligand
This study was supported by the Deutsche Forschungsgemeinschaft,
Bonn (Schr 211-19-3, Schr 211-21-1-2 and Sa 789-1-3). E.S. was
supported by the Swiss National Science Foundation Grant 3100-
064789.01-1 and M.Z.Q. by the King’s College London BBB
Consortium with Industry. We are most grateful to Hans Boehme
from Leibniz Institute for Neurobiology (Magdeburg, Germany) for
generously providing gerbils. We thank Prof. Joan Abbott for her
helpful suggestions on this manuscript.
References
AVALLONE, R., ZANOLI, P., PUIA, G., KLEINSCHNITZ, M.,
SCHREIER, P. & BARALDI, M. (2000). Pharmacological profile
of apigenin, a flavonoid isolated from Matricaria chamomilla.
Biochem. Pharmacol., 59, 1387–1394.
BAKER, W., BROWN, N.C. & SCOTT, J.A. (1939). The synthesis of
5-hydroxy-8-methoxyflavone (primetin monomethyl ether).
J. Chem. Soc., 2, 1922–1927.
MARDER, M., ESTIU, G., BLANCH, L.B., VIOLA, H., WASOWSKI, C.,
MEDINA, J.H. & PALADINI, A.C. (2001). Molecular modeling and
QSAR analysis of the interaction of flavone derivatives with the
benzodiazepine binding site of the GABAA receptor complex.
Bioorg. Med. Chem., 9, 323–335.
MARDER, M., VIOLA, H., WASOWSKI, C., FERNANDEZ, S.,
MEDINA, J.H. & PALADINI, A.C. (2003). 6-Methylapigenin and
hesperidin: new valeriana flavonoids with activity on the CNS.
Pharm. Biochem. Behav., 75, 537–545.
MEDINA, J.H., VIOLA, H., WOLFMAN, C., MARDER, M.,
WASOWSKI, C., CALVO, D. & PALADINI, A.C. (1998). Neuroactive
flavonoids: new ligands for the benzodiazepine receptors. Phyto-
medicine, 5, 235–243.
RAUSCH, W.-D., GOLECH, S., RIEDERER, P. & WEISER, M. (1988).
Inhibitory activity of tranquilizers, antiepileptics, calcium antago-
nists, sedatives and other compounds on the epileptiform seizures in
the Mongolian gerbil. New Trends in Clinical Neuropharmacol.
London: John Libbey Co Ltd, London, pp. 55–58.
SIEGHART, W. & SPERK, G. (2002). Subunit composition, distribution
and function of GABAA receptor subtypes. Curr. Top. Med. Chem.,
2, 795–816.
SIGEL, E. (1987). Properties of single sodium channels translated by
Xenopus oocytes after injection with messenger ribonucleic acid.
J. Physiol. (Lond.), 386, 73–90.
SIGEL, E. & BUHR, A. (1997). The benzodiazepine binding site of
GABAA receptors. Trends Pharmacol. Sci., 18, 425–429.
SIGEL, E., BAUR, R., TRUBE, G., MOHLER, H. & MALHERBE, P.
(1990). The effect of subunit composition of rat brain GABAA
receptors on channel function. Neuron, 5, 703–711.
SPENCER, J.P.E., CHOWRIMOOTOO, G., CHOUDHURY, R.,
DEBNAM, E.S., SREI, S.K. & RICE-EVANS, C. (1999). The small
intestine can both absorb and glucuronidate luminal flavonoids.
FEBS Lett., 458, 224–230.
SRIVASTAVA, S.D. & SRIVASTAVA, S.K. (1987). Synthesis of anew
flavone. Indian J. Chem., 26B, 57–58.
TAKASATO, Y., RAPOPORT, S.I. & SMITH, Q.R. (1984). An in situ
brain perfusion technique to study cerebrovascular transport in the
rat. Am. J. Physiol., 247, H484–H493.
TAN, R.X., LU, H., WOLFENDER, J.L., YU, T.T., ZHENG, W.F.,
YANG, L., GAFNER, S. & HOSTETTMANN, K. (1999). Mono- and
sesquiterpenes and antifungal constituents from Artemisia species.
Planta Med., 65, 64–67.
TREIMAN, D.M. (2001). GABAergic mechanisms in epilepsy. Epilepsia,
42 (Suppl. 3), 8–12.
VIOLA, H., WASOWSKI, C., LEVI DE STEIN, M., WOLFMAN, C.,
SILVEIRA, R., DAJAS, F., MEDINA, J.H. & PALADINI, A.C. (1995).
Apigenin, acomponent of Matricaria recutita flowers, is acentral
benzodiazepine receptors-ligand with anxiolytic effects. Planta
Med., 61, 213–216.
BERTORELLI, R., ADAMI, M.
&
ONGINI, E. (1995). The
Mongolian gerbil in experimental epilepsy. Ital. J. Neurol. Sci.,
16, 101–106.
BOILEAU, A.J., BAUR, R., SHARKEY, L.M., SIGEL, E.
&
CZAJKOWSKI, C. (2002). The relative amount of cRNA coding
for g2 subunits affects stimulation by benzodiazepines in GABAA
receptors expressed in Xenopus oocytes. Neuropharmacology, 43,
695–700.
BRACON, F., GUITTARD, F., TAFFIN DE GIVENCHY, E.
&
CAMBON, A. (1999). Highly fluorinated monomeres precursors of
side-chain liquid cristalline polysiloxanes. J. Polym. Sci. A, 37,
4487–4496.
CHERPECK, R.E. (1998). Preparation and use of aromatic amides of
poly(oxyalkylene) carbamates as fuel additives, especially gasoline
deposit inhibitors. US Patent 5786499.
CHULASIRI, M., BUNYAPRAPHATSARA, N. & MOONGKARNDI, P.
(1992). Mutagenicity and antimutagenicity of hispidulin and
hortensin, the flavonoids from Millingtonia hortensis L. Environ.
Mol. Mutagen., 20, 307–312.
DANIEL, H. & WENZEL, U. (2003). Flavonoids and their possible role
in colon cancer prevention and therapy. Exogenous factors in
colonic carcinogenesis. In: Falk-Symposium, ed. Scheppa ch, W. &
Scheurlen, M. Vol. 128, pp. 264–274. Dordrecht: Kluwer Academic
Publisher.
EGLETON, R.D., ABBRUSCATO, T.J., THOMAS, S.A. & DAVIS, T.P.
(1998). Transport of opioid peptides into the central nervous
system. J. Pharm. Sci., 87, 1433–1439.
GIL, B., SANZ, M.J., TERENCIO, M.C., FERRANDIZ, M.L., BUSTOS,
G., PAYA, M., GUNASEGARAN, R. & ALCARAZ, M.J. (1994).
Effects of flvaonoids on Njanjanad humna recombinnat
synovial phospholipases A2 and inflammatory responses in mice.
Life Sci., 54, 333–338.
GOUTMAN, J.D., WAXEMBERG, M.D., DONATE-OLIVER, F.,
POMATA, P.E. & CALVO, D.J. (2003). Flavonoid modulation of
ionic currents mediated by GABA(A) and GABA(C) receptors. Eur.
J. Pharmacol., 461, 79–87.
HORIE, T., SHIBATA, K., YAMASHITA, K., KAWAMURA, Y.
TSUKAYAMA, M. (1997). Studies of the selective O-alkylation and
dealkylation of flavonoids. XXII. convenient method for
&
A
synthesizing 3,5,7-trihydroxy-6-methoxyflavones. Chem. Pharm.
Bull., 45, 446–451.
HUI, K.M., HUEN, M.S.Y., WANG, H.Y., ZHENG, H., SIGEL, E.,
BAUR, R., REN, H., LI, Z.W., WONG, J.T.-F. & XUE, H. (2002).
Anxiolytic effect of wogonin, abenzodizaepine receptor lignad
isolated from Scutellaria baicalensis Georgi. Biochem. Pharmacol.,
64, 1415–1424.
YOUDIM, K.A., DOBBIE, M.S., KUHNLE, G., PROTEGGENTE, A.,
ABBOTT, N.J.
& RICE-EVANS, C. (2003). Interaction between
flavonoids and the blood–brain barrier: in vitro studies.
J. Neurochem., 85, 180–192.
JAIN, A.C., GUPTA, S.M. & BAMNAH, P. (1985). Aromatic benzhy-
drylation: part III – synthesis of chromones of triphenylmethane
type. Indian J. Chem., 24B, 393–397.
YOUDIM, K.A., QAISER, M.Z., BEGLEY, D.J., RICE-EVANS, C.A. &
ABBOTT, N.J. (2004). Flavonoid permeability across an in situ model
of the blood–brain barrier. Free Radic. Biol. Med., 36, 592–604.
KAVVADIAS, D., MONSCHEIN, V., SAND, P., RIEDERER, P.
&
(Received November 27, 2003
Revised February 11, 2004
Accepted April 5, 2004)
SCHREIER, P. (2003). Constituents of sage (Salvia officinalis L.)
with in vitro affinity to human brain benzodiazepine receptor.
Planta Med., 69, 113–117.
British Journal of Pharmacology vol 142 (5)